[Ophthalmic use of amikacin (author's transl)].
D000038:Abscess / Q000188:drug therapy; D000328:Adult; D000613:Aminobutyrates / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002481:Cellulitis / Q000188:drug therapy; D002648:Child; D003320:Corneal Ulcer / Q000188:drug therapy; D009877:Endophthalmitis / Q000188:drug therapy; D005123:Eye / Q000378:metabolism; D005128:Eye Diseases / Q000188:drug therapy*; D005141:Eyelid Diseases / Q000188:drug therapy; D005260:Female; D006726:Hordeolum / Q000188:drug therapy; D006801:Humans; D007267:Injections; D007273:Injections, Intramuscular; D007612:Kanamycin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011817:Rabbits; D013210:Staphylococcus / Q000187:drug effects
D000613:Aminobutyrates; D007612:Kanamycin